StageSeries A | Alive
Last Raised$23M | 4 yrs ago
Missing: Rheostat Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Rheostat Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Rheostat Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Rheostat Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Latest Rheostat Therapeutics News
Mar 22, 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Caraway’s CEO, Martin D. Williams, will give a presentation and take 1-on-1 investor meetings at the Stifel CNS Days event on March 29, 2023.
Rheostat Therapeutics Frequently Asked Questions (FAQ)
Where is Rheostat Therapeutics's headquarters?
Rheostat Therapeutics's headquarters is located at Cambridge.
What is Rheostat Therapeutics's latest funding round?
Rheostat Therapeutics's latest funding round is Series A.
How much did Rheostat Therapeutics raise?
Rheostat Therapeutics raised a total of $23M.
Who are the investors of Rheostat Therapeutics?
Investors of Rheostat Therapeutics include SV Health Investors, Amgen Ventures, Mayo Clinic, AbbVie Biotech Ventures, MRL Ventures and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.